Cargando…
Adjuvant Chemotherapy after Neoadjuvant Chemotherapy and Long-term Outcomes of CAPOX Plus Bevacizumab Followed by TME for High-risk Localized Rectal Cancer
OBJECTIVES: We previously reported the feasibility of neoadjuvant capecitabine and oxaliplatin plus bevacizumab as a treatment for locally advanced rectal cancer (UMIN000003219). The aim of this study is to investigate the prognostic relevance of neoadjuvant chemotherapy followed by total mesorectal...
Autores principales: | Nishimura, Junichi, Hasegawa, Junichi, Noura, Shingo, Ikeda, Kimimasa, Yasui, Masayoshi, Komori, Takamichi, Tsujie, Masaki, Yasumasa, Keigo, Shingai, Tatsushi, Uemura, Mamoru, Hata, Taishi, Matsuda, Chu, Mizushima, Tsunekazu, Ikeda, Masataka, Doki, Yuichiro, Mori, Masaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Society of Coloproctology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7390618/ https://www.ncbi.nlm.nih.gov/pubmed/32743112 http://dx.doi.org/10.23922/jarc.2019-042 |
Ejemplares similares
-
Survival outcomes of appendiceal mucinous neoplasms by histological type and stage: Analysis of 266 cases in a multicenter collaborative retrospective clinical study
por: Sueda, Toshinori, et al.
Publicado: (2019) -
Long-term outcome of adrenalectomy for metastasis resulting from colorectal cancer with other metastatic sites: A report of 3 cases
por: Uemura, Mamoru, et al.
Publicado: (2016) -
Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study
por: Mizushima, Tsunekazu, et al.
Publicado: (2019) -
Randomized phase II study of S-1 dosing schedule for resected colorectal cancer
por: Matsuda, Chu, et al.
Publicado: (2015) -
Single-site laparoscopic colectomy for rectosigmoid cancer with middle aortic syndrome: report of a case
por: Tamai, Koki, et al.
Publicado: (2015)